TR199903271T2 - Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�. - Google Patents

Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.

Info

Publication number
TR199903271T2
TR199903271T2 TR1999/03271T TR9903271T TR199903271T2 TR 199903271 T2 TR199903271 T2 TR 199903271T2 TR 1999/03271 T TR1999/03271 T TR 1999/03271T TR 9903271 T TR9903271 T TR 9903271T TR 199903271 T2 TR199903271 T2 TR 199903271T2
Authority
TR
Turkey
Prior art keywords
tozlar
soluma
prolipozom
tokoferol
karl
Prior art date
Application number
TR1999/03271T
Other languages
Turkish (tr)
Inventor
Bystr�m Katarina
Nilsson Per-Gunnar
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of TR199903271T2 publication Critical patent/TR199903271T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Abstract

Bulus, birinci aktif madde olarak formoterol ya da onun bir tuz ya da çözelti türevini ve ikinci bir aktif madde olarak ropfleponid ya da onun yagli bir esterini içeren bir kompozisyon ya da bilesim saglar. Ayrica solunum bozukluklarini tedavi etmek için bu kompozisyon ya da bilesimi kullanan metod da açiklanir.The invention provides a composition or composition comprising formoterol as the first active ingredient, or a salt or solution derivative thereof, and ropfleponid, or an oily ester thereof, as a second active ingredient. Also disclosed is the method that uses this composition or composition to treat respiratory disorders.

TR1999/03271T 1997-06-27 1998-06-08 Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�. TR199903271T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27

Publications (1)

Publication Number Publication Date
TR199903271T2 true TR199903271T2 (en) 2000-08-21

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03271T TR199903271T2 (en) 1997-06-27 1998-06-08 Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.

Country Status (18)

Country Link
EP (1) EP1001749A1 (en)
JP (1) JP2002510311A (en)
KR (1) KR20010014163A (en)
CN (1) CN1260713A (en)
AU (1) AU729100B2 (en)
BR (1) BR9810280A (en)
CA (1) CA2295028A1 (en)
EE (1) EE9900601A (en)
HU (1) HUP0003207A3 (en)
ID (1) ID23192A (en)
IL (1) IL133478A0 (en)
IS (1) IS5304A (en)
NO (1) NO996439L (en)
NZ (1) NZ501672A (en)
PL (1) PL337723A1 (en)
SK (1) SK184899A3 (en)
TR (1) TR199903271T2 (en)
WO (1) WO1999000111A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138310A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138313A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
RS53329B (en) * 2005-06-09 2014-10-31 Meda Ab Method and composition for treating inflammatory disorders
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
CN105188415A (en) * 2013-05-06 2015-12-23 帝斯曼知识产权资产管理有限公司 Powderous vitamin E formulation
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
CN105078963B (en) * 2015-09-29 2018-06-22 中山大学 Alpha-tocopherol is preparing the application in treating snail fever drug
JP2020503269A (en) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド Oral testosterone undecanoate therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation

Also Published As

Publication number Publication date
BR9810280A (en) 2000-09-12
HUP0003207A3 (en) 2001-03-28
NO996439L (en) 2000-02-28
CN1260713A (en) 2000-07-19
IS5304A (en) 1999-12-15
EE9900601A (en) 2000-08-15
AU729100B2 (en) 2001-01-25
WO1999000111A1 (en) 1999-01-07
SK184899A3 (en) 2000-05-16
AU7945698A (en) 1999-01-19
CA2295028A1 (en) 1999-01-07
HUP0003207A2 (en) 2001-02-28
ID23192A (en) 2000-03-23
IL133478A0 (en) 2001-04-30
NZ501672A (en) 2001-06-29
PL337723A1 (en) 2000-08-28
KR20010014163A (en) 2001-02-26
NO996439D0 (en) 1999-12-23
EP1001749A1 (en) 2000-05-24
JP2002510311A (en) 2002-04-02

Similar Documents

Publication Publication Date Title
TR199903271T2 (en) Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.
TR200100922T2 (en) Application of active substances through the lungs.
BR0314354A (en) Formation for lipophilic people
CY1116988T1 (en) BETA-L-2'-DEOXY-NUCLEOZES FOR USE TREATMENT B
DE69530926D1 (en) AGENTS FOR PROMOTING HAIR GROWTH
BR9904719A (en) Composition to increase the permeability of topical agents to the skin
PT1129093E (en) PIRAZPOLOPYRYIDINONE DERIVATIVES FOR THE TREATMENT OF IMPOTENCE
MA26548A1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING RESORCINOL DERIVATIVES.
ATE283031T1 (en) NON-IRRITATIVE COSMETIC AND PHARMACEUTICAL COMPOSITIONS
BR9712491A (en) Cosmetic compositions
PT902789E (en) ANDROSTENE DERIVATIVES
BR9811099A (en) Urokinase inhibitors
DE69807065T2 (en) TOPICAL AGENT
BR9804027A (en) New beta-keto esters
ES2136252T3 (en) TREATMENT OF DISEASES CAUSED BY SEBACEA GLAND DISORDERS THROUGH THE USE OF ACIL COA CHOLESTEROL ACIL TRANSFERASE INHIBITORS.
BR9707551A (en) Compositions containing an antifungal and a sulfur compound.
UA35611C2 (en) Topical composition for inhibiting hair growth in mammals, method for application and topical composition for delivering water-soluble pharmaceutical to skin
BR9809848A (en) Composition
DE69822366D1 (en) Aqueous emulsion composition
BR9901392A (en) Hydroxymethylhexanones as flavoring agents.
ATE158947T1 (en) SKIN REGENERATING COSMETIC COMPOSITION
EA199900750A1 (en) AQUEOUS PHARMACEUTICAL COMPOSITION, INCLUDING THE ACTIVE INGREDIENT, IN THE HIGHEST DEGREE IN THE WATER
TR199903272T2 (en) New knowledge of asthma prescription drugs.
TR199901374T2 (en) Insecticidal and miticidal compositions
ES2166816T3 (en) PIRIDIL-IMIDAZOLIC DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.